Quick Overview: Dr. Darien Sutton discusses how the FDA is working to take steps to strengthen its oversight of a category of medical The VALID Act, currently being considered in Congress, Presented By: Dr. Vijay Singh Speaker Biography: Dr. Vijay Singh is the Director of Molecular Diagnostics at HealthTrackRx in ...
Lab Develops Test That Can - Detailed Overview & Context
Dr. Darien Sutton discusses how the FDA is working to take steps to strengthen its oversight of a category of medical The VALID Act, currently being considered in Congress, Presented By: Dr. Vijay Singh Speaker Biography: Dr. Vijay Singh is the Director of Molecular Diagnostics at HealthTrackRx in ... In this webinar, Dr. Vijay Singh, Director of Molecular Diagnostics at HealthTrackRx, shares his experience of bringing an ... Haynes Boone Associates Kayla Cristales and Luke Nguyen discuss the FDA's recently issued Final Rule changing the Agency's ... William Morice II, M.D., Ph.D., chair of the Department of
The Simple, Sensible, Salient & Still Spell-Binding Seven Questions about In late November, the U.S. Department of Health and Human Services (HHS) withdrew a policy regarding Now that the U.S. FDA has issued its long-awaited final rule on new oversight requirements for Presentation by Dr John Reddington PhD, DVM, Chief Operating Officer of Cambridge Biomedical. John discusses the recent ...
